[Retracted] (5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate from <i>Euclea crispa</i> (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms

<div>Effect of compound 2 on C-X-C motif chemokine receptor 4 (CXCR 4), human epidermal growth factor receptor 2 (HER2), and Akt protein expression in HO-8910 cells. Cells were treated with 30 and 40 <i>μ</i>g of compound for 24 h. The protein levels were quantified using densitometry analysis and are expressed in relative intensity arbitrary unit. Each bar represents mean ± SEM of six independent observations. (a) Compared to control; (b) compared to 30 <i>μ</i>g of compound 2.</div>

Bioinorganic Chemistry and Applications

fig9

Figure 9

Figure 9: [Retracted] (5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate from <i>Euclea crispa</i> (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms 

Figure 9 | [Retracted] (5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate from Euclea crispa (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms 